At the 6-month follow-up , neurofeedback participants maintained the same stimulant medication dosage , whereas participants in both CT and control conditions showed statistically and clinically significant increases ( 9 mg [ P = .002 ] and 13 mg [ P < .001 ] , respectively ) .